Overview

For healthcare providers

Clinical outcomes with Aquablation® therapy

of patients avoided another BPH intervention at 5 years
of men with BPH preserved ejaculatory function
preserved continence after treatment
In clinical studies, Aquablation therapy demonstrated long-lasting symptom relief with low rates of irreversible complications.1,2

Proven, precise, and 
predictable BPH treatment

Aquablation therapy is the only ultrasound-guided, robotic-assisted, waterjet treatment for BPH across prostates of all shapes and sizes.

The next-generation, AI-powered, robotic platform for Aquablation therapy

  • AI-powered treatment planning
  • Advanced image guidance
  • Robotic resection
  • Streamlined workflow
Clinical Data

Demonstrated safety and efficacy with clinical evidence

Learn more about the studies and data from PROCEPT BioRobotics® clinical studies.

>150

peer-reviewed publications

>50,000

procedures
References:
  1. Gilling PJ, et al. Can J Urol 2022.
  2. Elterman D, et al. BMJ Surg Interv Health Technol 2021.